Effects of Angiotensin-Neprilysin Inhibition in Canines with Experimentally-Induced Cardiorenal Syndrome

BACKGROUND: Sacubitril/Valsartan (Sac/Val), a combined angiotensin-II receptor blocker (Val) and neprilysin inhibitor (Sac) in a 1:1 molar ratio, was shown to reduce the risk of cardiovascular death or heart failure (HF) hospitalization in patients with HF and reduced LV ejection fraction (EF). This...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Card Fail
Main Authors: Sabbah, Hani N., Zhang, Kefei, Gupta, Ramesh C., Jiang-Xu, Singh-Gupta, Vinita
Formato: Artigo
Idioma:Inglês
Publicado: 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7704862/
https://ncbi.nlm.nih.gov/pubmed/32841710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cardfail.2020.08.009
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares